News Releases

News and information from The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society and Sylvan Learning Partner to Help Kids with Cancer

Contact: Marcie Klein
Tel: (914) 821-8205
marcie.klein@lls.org White Plains, N.Y. (May 29, 2014) -- While extraordinary progress has been made in treating childhood leukemia and other pediatric cancers in recent years, critical attention must also be paid to the educational and emotional challenges facing kids re-entering school after treatment. The Leukemia & Lymphoma Society (LLS) and Sylv...

Harry T. Mangurian Jr. Foundation Commits $4 Million to Help Beat AML

Contact: Andrea Greif
Tel: (914) 821-8958
Cell: (914) 772-3027
andrea.greif@lls.org
News Release White Plains, N.Y. (May 22, 2014) - The Leukemia & Lymphoma Society (LLS) today announced a $4 million commitment by the Harry T. Mangurian, Jr. Foundation to support a groundbreaking collaboration between LLS and with Brian Druker, M.D., of Oregon Health and Science University ...

Francie Heller, Managing Partner at Heller Advisory, Elected to The Leukemia & Lymphoma Society National Board of Directors

Contact: Andrea Greif
Tel: (914) 821-8958
Cell: (914) 772-3027
andrea.greif@lls.org
News Release White Plains, N.Y. (May 15, 2014) - Francie Heller, managing partner at Heller Advisory, has been elected to the national board of directors of The Leukemia & Lymphoma Society (LLS), effective July 1, 2014.  Her term will run through June 30, 2017. Heller has more than t...

William S. Dalton, Founder and CEO of M2Gen, Elected to The Leukemia & Lymphoma Society National Board of Directors

Contact: Andrea Greif
Tel: (914) 821-8958
Cell: (914) 772-3027
andrea.greif@lls.org   News Release William S. Dalton, Founder and CEO of M2Gen, Elected to The Leukemia & Lymphoma Society National Board of Directors  White Plains, N.Y. (May 15, 2014) - William S. Dalton, PhD., M.D., founder and CEO of M2Gen, a national biotechnology subsidiary of Moffitt Cancer ...

Pages

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: